Quinpramine: revival of old anti-inflammatory principles in multiple sclerosis?
Haghikia
Aiden
A
Department of Neurology, Ruhr-University Bochum, St. Josef-Hospital, Gudrunstr. 56, D-44791 Bochum, Germany.
Gold
Ralf
R
D000166:Acridines / Q000138:chemical synthesis / Q000494:pharmacology* / Q000627:therapeutic use; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000138:chemical synthesis / Q000494:pharmacology* / Q000627:therapeutic use; D001596:Benzylamines / Q000138:chemical synthesis / Q000494:pharmacology* / Q000627:therapeutic use; D002784:Cholesterol / Q000378:metabolism; D004195:Disease Models, Animal; D004681:Encephalomyelitis, Autoimmune, Experimental / Q000188:drug therapy* / Q000276:immunology / Q000503:physiopathology; D006801:Humans; D054992:Immunological Synapses / Q000187:drug effects / Q000276:immunology / Q000378:metabolism; D007165:Immunosuppression Therapy / Q000379:methods*; D007166:Immunosuppressive Agents / Q000138:chemical synthesis / Q000494:pharmacology* / Q000627:therapeutic use; D051379:Mice; D009103:Multiple Sclerosis / Q000188:drug therapy* / Q000276:immunology / Q000503:physiopathology; D016896:Treatment Outcome
D000166:Acridines; D000893:Anti-Inflammatory Agents; D001596:Benzylamines; D007166:Immunosuppressive Agents; C541811:quinpramine; D002784:Cholesterol